Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factors

Detalhes bibliográficos
Autor(a) principal: McAllister, Nicole
Data de Publicação: 2020
Outros Autores: Liu, Yan, Silva, Lisete M., Lentscher, Anthony J., Chai, Wengang, Wu, Nian, Griswold, Kira A., Raghunathan, Krishnan, Vang, Lo, Alexander, Jeff, Warfield, Kelly L., Diamond, Michael S., Feizi, Ten, Silva, Laurie A., Dermody, Terence S.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/29873
Resumo: Chikungunya virus (CHIKV) is an arthritogenic alphavirus that causes debilitating musculoskeletal disease. CHIKV displays broad cell, tissue, and species tropism, which may correlate with the attachment factors and entry receptors used by the virus. Cell-surface glycosaminoglycans (GAGs) have been identified as CHIKV attachment factors. However, the specific types of GAGs and potentially other glycans to which CHIKV binds and whether there are strain-specific differences in GAG binding is not fully understood. To identify the types of glycans bound by CHIKV, we conducted glycan microarray analyses and discovered that CHIKV preferentially binds GAGs. Microarray results also indicate that sulfate groups on GAGs are essential for CHIKV binding and that CHIKV binds most strongly to longer GAG chains of heparin and heparan sulfate. To determine whether GAG-binding capacity varies among CHIKV strains, a representative strain from each genetic clade was tested. While all strains directly bound to heparin and chondroitin sulfate in ELISAs and depended on heparan sulfate for efficient cell-binding and infection, we observed some variation by strain. Enzymatic removal of cell-surface GAGs and genetic ablation that diminishes GAG expression reduced CHIKV binding and infectivity of all strains. Collectively, these data demonstrate that GAGs are the preferred glycan bound by CHIKV, enhance our understanding of the specific GAG moieties required for CHIKV binding, define strain differences in GAG engagement, and provide further evidence for a critical function of GAGs in CHIKV cell attachment and infection.IMPORTANCE Alphavirus infections are a global health threat, contributing to outbreaks of disease in many parts of the world. Recent epidemics caused by CHIKV, an arthritogenic alphavirus, resulted in more than 8.5 million cases as the virus has spread into new geographic regions, including the Western Hemisphere. CHIKV causes disease in the majority of people infected, leading to severe and debilitating arthritis. Despite the severity of CHIKV disease, there are no licensed therapeutics. Since attachment factors and receptors are determinants of viral tropism and pathogenesis, understanding these virus-host interactions can enhance our knowledge of CHIKV infection. We analyzed over 670 glycans and identified GAGs as the main glycan bound by CHIKV. We defined specific GAG components required for CHIKV binding and assessed strain-specific differences in GAG-binding capacity. These studies provide insight about cell-surface molecules that CHIKV binds, which could facilitate the development of antiviral therapeutics targeting the CHIKV attachment step.
id RCAP_b764b35cf1ff3c39c4182e69373fd2e6
oai_identifier_str oai:ria.ua.pt:10773/29873
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factorsAttachment factorsGlycan microarraysGlycosaminoglycansHeparan sulfateAlphavirusChikungunya virusGlycansChikungunya virus (CHIKV) is an arthritogenic alphavirus that causes debilitating musculoskeletal disease. CHIKV displays broad cell, tissue, and species tropism, which may correlate with the attachment factors and entry receptors used by the virus. Cell-surface glycosaminoglycans (GAGs) have been identified as CHIKV attachment factors. However, the specific types of GAGs and potentially other glycans to which CHIKV binds and whether there are strain-specific differences in GAG binding is not fully understood. To identify the types of glycans bound by CHIKV, we conducted glycan microarray analyses and discovered that CHIKV preferentially binds GAGs. Microarray results also indicate that sulfate groups on GAGs are essential for CHIKV binding and that CHIKV binds most strongly to longer GAG chains of heparin and heparan sulfate. To determine whether GAG-binding capacity varies among CHIKV strains, a representative strain from each genetic clade was tested. While all strains directly bound to heparin and chondroitin sulfate in ELISAs and depended on heparan sulfate for efficient cell-binding and infection, we observed some variation by strain. Enzymatic removal of cell-surface GAGs and genetic ablation that diminishes GAG expression reduced CHIKV binding and infectivity of all strains. Collectively, these data demonstrate that GAGs are the preferred glycan bound by CHIKV, enhance our understanding of the specific GAG moieties required for CHIKV binding, define strain differences in GAG engagement, and provide further evidence for a critical function of GAGs in CHIKV cell attachment and infection.IMPORTANCE Alphavirus infections are a global health threat, contributing to outbreaks of disease in many parts of the world. Recent epidemics caused by CHIKV, an arthritogenic alphavirus, resulted in more than 8.5 million cases as the virus has spread into new geographic regions, including the Western Hemisphere. CHIKV causes disease in the majority of people infected, leading to severe and debilitating arthritis. Despite the severity of CHIKV disease, there are no licensed therapeutics. Since attachment factors and receptors are determinants of viral tropism and pathogenesis, understanding these virus-host interactions can enhance our knowledge of CHIKV infection. We analyzed over 670 glycans and identified GAGs as the main glycan bound by CHIKV. We defined specific GAG components required for CHIKV binding and assessed strain-specific differences in GAG-binding capacity. These studies provide insight about cell-surface molecules that CHIKV binds, which could facilitate the development of antiviral therapeutics targeting the CHIKV attachment step.American Society for Microbiology2020-112020-11-01T00:00:00Z2021-11-30T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10773/29873eng0022-538X10.1128/JVI.01500-20McAllister, NicoleLiu, YanSilva, Lisete M.Lentscher, Anthony J.Chai, WengangWu, NianGriswold, Kira A.Raghunathan, KrishnanVang, LoAlexander, JeffWarfield, Kelly L.Diamond, Michael S.Feizi, TenSilva, Laurie A.Dermody, Terence S.info:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T11:57:43Zoai:ria.ua.pt:10773/29873Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:02:04.434565Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factors
title Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factors
spellingShingle Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factors
McAllister, Nicole
Attachment factors
Glycan microarrays
Glycosaminoglycans
Heparan sulfate
Alphavirus
Chikungunya virus
Glycans
title_short Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factors
title_full Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factors
title_fullStr Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factors
title_full_unstemmed Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factors
title_sort Chikungunya virus strains from each genetic clade bind sulfated glycosaminoglycans as attachment factors
author McAllister, Nicole
author_facet McAllister, Nicole
Liu, Yan
Silva, Lisete M.
Lentscher, Anthony J.
Chai, Wengang
Wu, Nian
Griswold, Kira A.
Raghunathan, Krishnan
Vang, Lo
Alexander, Jeff
Warfield, Kelly L.
Diamond, Michael S.
Feizi, Ten
Silva, Laurie A.
Dermody, Terence S.
author_role author
author2 Liu, Yan
Silva, Lisete M.
Lentscher, Anthony J.
Chai, Wengang
Wu, Nian
Griswold, Kira A.
Raghunathan, Krishnan
Vang, Lo
Alexander, Jeff
Warfield, Kelly L.
Diamond, Michael S.
Feizi, Ten
Silva, Laurie A.
Dermody, Terence S.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv McAllister, Nicole
Liu, Yan
Silva, Lisete M.
Lentscher, Anthony J.
Chai, Wengang
Wu, Nian
Griswold, Kira A.
Raghunathan, Krishnan
Vang, Lo
Alexander, Jeff
Warfield, Kelly L.
Diamond, Michael S.
Feizi, Ten
Silva, Laurie A.
Dermody, Terence S.
dc.subject.por.fl_str_mv Attachment factors
Glycan microarrays
Glycosaminoglycans
Heparan sulfate
Alphavirus
Chikungunya virus
Glycans
topic Attachment factors
Glycan microarrays
Glycosaminoglycans
Heparan sulfate
Alphavirus
Chikungunya virus
Glycans
description Chikungunya virus (CHIKV) is an arthritogenic alphavirus that causes debilitating musculoskeletal disease. CHIKV displays broad cell, tissue, and species tropism, which may correlate with the attachment factors and entry receptors used by the virus. Cell-surface glycosaminoglycans (GAGs) have been identified as CHIKV attachment factors. However, the specific types of GAGs and potentially other glycans to which CHIKV binds and whether there are strain-specific differences in GAG binding is not fully understood. To identify the types of glycans bound by CHIKV, we conducted glycan microarray analyses and discovered that CHIKV preferentially binds GAGs. Microarray results also indicate that sulfate groups on GAGs are essential for CHIKV binding and that CHIKV binds most strongly to longer GAG chains of heparin and heparan sulfate. To determine whether GAG-binding capacity varies among CHIKV strains, a representative strain from each genetic clade was tested. While all strains directly bound to heparin and chondroitin sulfate in ELISAs and depended on heparan sulfate for efficient cell-binding and infection, we observed some variation by strain. Enzymatic removal of cell-surface GAGs and genetic ablation that diminishes GAG expression reduced CHIKV binding and infectivity of all strains. Collectively, these data demonstrate that GAGs are the preferred glycan bound by CHIKV, enhance our understanding of the specific GAG moieties required for CHIKV binding, define strain differences in GAG engagement, and provide further evidence for a critical function of GAGs in CHIKV cell attachment and infection.IMPORTANCE Alphavirus infections are a global health threat, contributing to outbreaks of disease in many parts of the world. Recent epidemics caused by CHIKV, an arthritogenic alphavirus, resulted in more than 8.5 million cases as the virus has spread into new geographic regions, including the Western Hemisphere. CHIKV causes disease in the majority of people infected, leading to severe and debilitating arthritis. Despite the severity of CHIKV disease, there are no licensed therapeutics. Since attachment factors and receptors are determinants of viral tropism and pathogenesis, understanding these virus-host interactions can enhance our knowledge of CHIKV infection. We analyzed over 670 glycans and identified GAGs as the main glycan bound by CHIKV. We defined specific GAG components required for CHIKV binding and assessed strain-specific differences in GAG-binding capacity. These studies provide insight about cell-surface molecules that CHIKV binds, which could facilitate the development of antiviral therapeutics targeting the CHIKV attachment step.
publishDate 2020
dc.date.none.fl_str_mv 2020-11
2020-11-01T00:00:00Z
2021-11-30T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/29873
url http://hdl.handle.net/10773/29873
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0022-538X
10.1128/JVI.01500-20
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv American Society for Microbiology
publisher.none.fl_str_mv American Society for Microbiology
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137676213878784